Fluorescence in situ hybridization on methylcellulose cultured hematopoietic stem cells from myelodysplastic syndromes

被引:7
|
作者
Dupont, JM
Fontenay-Roupie, M
Dupuy, O
Lebarr, A
Le Tessier, D
Auvinet, P
Rabineau, D
Fichelson, S
机构
[1] Grp Hosp Cochin, Lab Rech Hemobiol, F-75014 Paris, France
[2] Serv Histol Embryol Cytogenet, Paris, France
[3] Hop Cochin, Hematol Lab, F-75674 Paris, France
关键词
D O I
10.1016/S0165-4608(97)00061-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Myelodysplastic syndromes (MDS) are clonal malignancies characterized by peripheral blood pancytopenia and signs of maturation disturbances of one or several cell lineages in bone marrow. MDS present as chimeras associating normal polyclonal and malignant monoclonal progenitors cells in various proportions, Numerous cytogenetic abnormalities have been reported in MDS and can be defected by fluorescence in situ hybridization (FISH) on interphase cells. We have used this technique on methylcellulose cultured hematopoietic progenitors obtained from three patients suffering from MDS and exhibiting informative karyotypic features, Hematopoietic cells were cultured for 14 days, and individual clones (BFU-E, CFU-GM) were picked up and then cytocentrifuged for FISH analysis. We used centromeric probes realized and labeled in our laboratory by PCR to defect aneuploidies for chromosomes 7 and 11 in two patients, Furthermore, we could detect a 5q partial deletion on interphase cells from the third patient using a 5q31 specific probe visualized with the HNPP Fluorescent Detection Set from Boehringer Mannheim(R). In conclusion, FISH is a helpful method to detect malignant clones in hematopoietic progenitor cultures and hence to study the relative growth of normal vs. leukemic cells in MDS. (C) Elsevier Science Inc., 1998.
引用
收藏
页码:12 / 15
页数:4
相关论文
共 50 条
  • [1] Cytogenetic characterization by array comparative genomic hybridization and fluorescence in situ hybridization of mesenchymal stem cells from patients with myelodysplastic syndromes
    Lopez Villar, O.
    Sanchez-Guijo, F. M.
    Garcia, J. L.
    Villaron, E.
    Lopez-Holgado, N.
    Perez Simon, J. A.
    San Miguel, J.
    Del Canizo, M. C.
    LEUKEMIA RESEARCH, 2007, 31 : S52 - S52
  • [2] Cytogenetic hybridization by array comparative genomic hybridization and fluorescence in situ hibridization of mesenchymal stem cells from patients with myelodysplastic syndromes
    Lopez Villar, O.
    Sanchez-Guijo, F. Martin
    Garcia, J. L.
    Villaron, E.
    Lopez-Holgado, N.
    Perez Simon, J. A.
    San Miguel, J.
    Canizo, M. C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 158 - 158
  • [3] The importance of fluorescence in situ hybridization analysis in myelodysplastic syndromes
    Karaca, Emin
    JOURNAL OF BIOTECHNOLOGY, 2014, 185 : S13 - S13
  • [4] The Usefulness of Fluorescence In Situ Hybridization in the Diagnosis of Myelodysplastic Syndromes
    Kwok, B.
    Loghavi, S.
    Hussong, J.
    Alsabeh, R.
    MODERN PATHOLOGY, 2010, 23 : 308A - 308A
  • [5] The Usefulness of Fluorescence In Situ Hybridization in the Diagnosis of Myelodysplastic Syndromes
    Kowk, B.
    Loghavi, S.
    Hussong, J.
    Alsabeh, R.
    LABORATORY INVESTIGATION, 2010, 90 : 308A - 308A
  • [6] Clonal chromosomal abnormalities identified by interphase fluorescence in situ hybridization on collagen cultured hematopoietic stem cells
    D Le Tessier
    JM Dupont
    S Fichelson
    D Bouscary
    A Lebbar
    F Dreyfus
    D Rabineau
    Leukemia, 2000, 14 : 949 - 950
  • [7] Clonal chromosomal abnormalities identified by interphase fluorescence in situ hybridization on collagen cultured hematopoietic stem cells
    Le Tessier, D
    Dupont, JM
    Fichelson, S
    Bouscary, D
    Lebbar, A
    Dreyfus, F
    Rabineau, D
    LEUKEMIA, 2000, 14 (05) : 949 - 950
  • [8] Fluorescence in situ hybridization on dysplasia cells for the study of clonal origin and evolution in myelodysplastic syndromes
    Chunmei, F. U.
    Liu, D.
    Zhang, J. U. N.
    Pan, J.
    Chen, Z.
    LEUKEMIA RESEARCH, 2013, 37 : S130 - S130
  • [9] Myelodysplastic syndromes are multiclonal diseases derived from hematopoietic stem and progenitor cells
    Bingqing Luo
    Fang Dong
    Tiejun Qin
    Qingyun Zhang
    Haitao Bai
    Jinhong Wang
    Yujiao Jia
    Shihui Ma
    Erlie Jiang
    Tao Cheng
    Zhijian Xiao
    Hideo Ema
    Experimental Hematology & Oncology, 11
  • [10] In vitro expansion of repopulating hematopoietic stem cells from patients with Myelodysplastic Syndromes
    Altrock, E.
    Danner, J.
    Jann, J. -C.
    Flach, J.
    Schmitt, N.
    Nowak, V.
    Oblaender, J.
    Pressler, J.
    Palme, I.
    Wuchter, P.
    Drangmeister, L.
    La Meir, F.
    Nolte, F.
    Metzgeroth, G.
    Hofmann, W. -K.
    Nowak, D.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 92 - 92